Item 8.01. Other Events.
On
On
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements, including
statements regarding future results, performance or achievements. These
statements involve known and unknown risks, uncertainties and other factors
which may cause the Company's actual results, performance or achievements to be
materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements. These statements reflect
our current views with respect to future events and are based on assumptions and
are subject to risks and uncertainties. Given these uncertainties, you should
not place undue reliance on these forward-looking statements. Some of the
factors that could affect the forward-looking statements contained herein
include: that developing any HAE product candidate may take longer or may be
more expensive than planned; that ongoing and future preclinical and clinical
development of BCX9930, BCX9250 and may not have positive results; that BioCryst
may not be able to enroll the required number of subjects in planned clinical
trials of product candidates; that the company may not advance human clinical
trials with product candidates as expected; that the FDA, EMA, PMDA or other
applicable regulatory agency may require additional studies beyond the studies
planned for product candidates, or may not provide regulatory clearances which
may result in delay of planned clinical trials, or may impose a clinical hold
with respect to such product candidate, or withhold market approval for product
candidates; that actual financial results may not be consistent with
expectations, including that 2019 operating expenses and cash usage may not be
within management's expected ranges. Please refer to the documents the Company
files periodically with the
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description Press release datedDecember 11, 2019 entitled "BioCryst Submits 99.1 New Drug Application for Oral, Once Daily Berotralstat (BCX7353) to Prevent HAE Attacks"
--------------------------------------------------------------------------------
© Edgar Online, source